Syndax Pharmaceuticals draws focus after stock decline as mixed earnings and oncology pipeline developments shape sentiment ...

Thank you, Ben, and good morning, everyone. In addition to the consistent performance of Jakafi in 2024, we saw strong growth from our non-Jakafi revenue, primarily driven by Opzelura, highlighting ...

Operator: Good day, and thank you for standing by. Welcome to the First Quarter 2026 Agios Financial Results and Business ...

Good morning, everyone, and thank you for joining us on today's call to discuss our third quarter highlights beginning on the next slide. First, we have multiple high-value catalysts in the coming ...

Leading aged care in-home support service, Enliven, has invested around $55,000 in specialised training equipment and ...

I'm Vince Ippolito, Executive Chairman of the Board of Botanix Pharmaceuticals Limited, and we're pleased to present the Botanix quarterly activity report and 4C quarterly cash flow report for the ...

Good afternoon, ladies and gentlemen, and welcome to South Plains Financial, Inc. First Quarter 2026 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.

What if all three teams with the best lottery odds fall out of the top four? Here's my full two-round mock draft with ...

Management emphasized that both revenue and adjusted EBITDA grew for the twelfth consecutive quarter, reflecting operational ...

Management anticipates "margin pressure" in Q2 and Q3 due to "timing differences between cost realization and recovery" and ...

The New York Giants have a multitude of needs entering Day 3 of the 2026 NFL draft and these are 10 prospects they could ...

Wednesday, April 29, 2026 at 10 a.m. ET. CALL PARTICIPANTS. Chairman and Chief Executive Officer — Michael Collins; President ...